SE9600716L - Adhesion inhibitors, preparations containing the same and process for their preparation - Google Patents

Adhesion inhibitors, preparations containing the same and process for their preparation

Info

Publication number
SE9600716L
SE9600716L SE9600716A SE9600716A SE9600716L SE 9600716 L SE9600716 L SE 9600716L SE 9600716 A SE9600716 A SE 9600716A SE 9600716 A SE9600716 A SE 9600716A SE 9600716 L SE9600716 L SE 9600716L
Authority
SE
Sweden
Prior art keywords
products
lactobacillus strains
preparation
strains producing
biological activity
Prior art date
Application number
SE9600716A
Other languages
Swedish (sv)
Other versions
SE508045C2 (en
SE9600716D0 (en
Inventor
Patricia Lynne Conway
Arthur Ouwehand
Original Assignee
Arla Ekonomisk Foerening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Ekonomisk Foerening filed Critical Arla Ekonomisk Foerening
Priority to SE9600716A priority Critical patent/SE508045C2/en
Publication of SE9600716D0 publication Critical patent/SE9600716D0/en
Priority to PCT/SE1997/000313 priority patent/WO1997030717A1/en
Priority to AU21089/97A priority patent/AU2108997A/en
Priority to CA 2243067 priority patent/CA2243067A1/en
Priority to EP97906380A priority patent/EP0904091A1/en
Publication of SE9600716L publication Critical patent/SE9600716L/en
Publication of SE508045C2 publication Critical patent/SE508045C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Products for inhibiting the adhesion of pathogens to gastrointestinal epithelial mucosa in animals including humans are described. The products contain high molecular weight carbohydrates produced by Lactobacillus strains of enteric origin preferably having a composition of N-acetylglucose-amine:galactose:glucose in a ratio of 1:3:2. There is also described preparations for oral administration comprising as active ingredient the products above, when purified, partially purified, or modified chemically while retaining the biological activity, as well as subunits and complexes thereof which retain the biological activity, or Lactobacillus strains producing the products, or culture supernatant resulting from culturing Lactobacillus strains producing the products. Further, there is described a method of preparation of the products by culturing Lactobacillus strains producing the products.
SE9600716A 1996-02-26 1996-02-26 Adhesion inhibitors, preparations containing the same and process for their preparation SE508045C2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9600716A SE508045C2 (en) 1996-02-26 1996-02-26 Adhesion inhibitors, preparations containing the same and process for their preparation
PCT/SE1997/000313 WO1997030717A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them
AU21089/97A AU2108997A (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them
CA 2243067 CA2243067A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them
EP97906380A EP0904091A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600716A SE508045C2 (en) 1996-02-26 1996-02-26 Adhesion inhibitors, preparations containing the same and process for their preparation

Publications (3)

Publication Number Publication Date
SE9600716D0 SE9600716D0 (en) 1996-02-26
SE9600716L true SE9600716L (en) 1997-08-27
SE508045C2 SE508045C2 (en) 1998-08-17

Family

ID=20401546

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600716A SE508045C2 (en) 1996-02-26 1996-02-26 Adhesion inhibitors, preparations containing the same and process for their preparation

Country Status (5)

Country Link
EP (1) EP0904091A1 (en)
AU (1) AU2108997A (en)
CA (1) CA2243067A1 (en)
SE (1) SE508045C2 (en)
WO (1) WO1997030717A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001010448A1 (en) * 1999-08-09 2001-02-15 University Of Maryland, Baltimore Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
MY170519A (en) 2014-12-23 2019-08-08 4D Pharma Res Ltd Immune modulation
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
LT3360559T (en) 2015-06-15 2019-12-27 4D Pharma Research Limited Compositions comprising bacterial strains
DK3240554T3 (en) 2015-06-15 2019-10-28 4D Pharma Res Ltd BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATMENT OF INFLAMMATORY AND AUTO-IMMUNE DISEASES
EA201890050A1 (en) 2015-06-15 2018-06-29 4Д Фарма Рисёрч Лимитед COMPOSITIONS CONTAINING BACTERIAL STRAINS
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
US9839655B2 (en) 2015-11-20 2017-12-12 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SI3313423T1 (en) 2016-03-04 2019-07-31 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TWI802545B (en) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
LT3630136T (en) 2017-05-22 2021-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
JP6978514B2 (en) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited Composition containing bacterial strain
MD3638271T2 (en) 2017-06-14 2021-03-31 4D Pharma Res Ltd Compositions comprising bacterial strains
IL292373A (en) 2017-06-14 2022-06-01 4D Pharma Res Ltd Compositions comprising a bacterial strain of the genus megasphera and uses thereof
SG11201912105PA (en) 2017-06-14 2020-01-30 4D Pharma Res Ltd Compositions comprising bacterial strains

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8900546D0 (en) * 1989-02-17 1989-02-17 Bioinvent Int Ab Means for inhibiting pathogens' growth and / or survival

Also Published As

Publication number Publication date
EP0904091A1 (en) 1999-03-31
SE508045C2 (en) 1998-08-17
SE9600716D0 (en) 1996-02-26
CA2243067A1 (en) 1997-08-28
AU2108997A (en) 1997-09-10
WO1997030717A1 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
SE9600716L (en) Adhesion inhibitors, preparations containing the same and process for their preparation
CA1246445A (en) Intestinal microflora-improving agent
TR200101049T2 (en) Cyclic tetrapeptide compound and its use
FI20012509A (en) New strains of Lactobacillus and their use in the production of food, in particular oatmeal
BG102100A (en) Method for the preparation of monomer con-conjugates of kalicheamycin derivative/carrier
DE69425671D1 (en) GLUCOSAMINE DISACCHARIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THEREOF AND THEIR USE
BR9809921A (en) Method for administering viable microorganism composition for poultry
MY116272A (en) Immunity enhancing lactic acid bacteria
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
CA1266234A (en) Method of binding microflora
DE69620271D1 (en) Haemophilus influenzae type b vaccine preparation containing polyribosylribitol phosphate and process for its preparation
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
US4364926A (en) Novel alkaline protease M3 method for the preparation thereof and dental caries-prophylactic composition containing the same
SE9704584L (en) Preparation of Conjugated Linoleic Acid
JPH05219942A (en) Variant of clostridium and histolyticum method for production thereof and usage thereof
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
CA2294670A1 (en) Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
CA2131681A1 (en) Antitumor agent
ES8505722A1 (en) Hypotriglyceridemically active polysaccharides.
CA1286623C (en) Liver function-improving agent and blood pressure- lowering agent
EP0856519A3 (en) Antibacterial insect protein
JPH0699314B2 (en) Macrophage activator
WO2003023045A1 (en) Sulfated polysaccharides, process for producing the same and substances having the same as the active ingredient
EP0936218A4 (en) Novel benzimidazole derivatives
UA70974C2 (en) Vancoresmycin (variants), strain AMYCOLATOPSIS of species HIL-006734, DSM 12216, producing thereof, and pharmaceutical composition having antibiotic activity

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9600716-6

Format of ref document f/p: F